Wei-Feng Huang

1.9k total citations · 1 hit paper
99 papers, 1.3k citations indexed

About

Wei-Feng Huang is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Wei-Feng Huang has authored 99 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 27 papers in Molecular Biology and 21 papers in Epidemiology. Recurrent topics in Wei-Feng Huang's work include Cancer-related molecular mechanisms research (9 papers), Gastrointestinal Tumor Research and Treatment (8 papers) and Mycobacterium research and diagnosis (8 papers). Wei-Feng Huang is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Gastrointestinal Tumor Research and Treatment (8 papers) and Mycobacterium research and diagnosis (8 papers). Wei-Feng Huang collaborates with scholars based in China, Taiwan and United States. Wei-Feng Huang's co-authors include Yingchuan Li, Yongmei Cao, Jiawei Shang, Ping Feng, Fang Wu, Qin Tan, Haijun Zhang, Jian Xiao, Xiaoping Zhang and Zhigang Mei and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Wei-Feng Huang

79 papers receiving 1.3k citations

Hit Papers

Inhibitor of apoptosis-stimulating protein of p53 inhibit... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei-Feng Huang China 18 677 375 300 258 160 99 1.3k
Rui Guo China 21 569 0.8× 183 0.5× 136 0.5× 220 0.9× 183 1.1× 74 1.4k
Xudong Feng China 19 454 0.7× 177 0.5× 148 0.5× 205 0.8× 177 1.1× 35 1.2k
Mayuko Osada‐Oka Japan 19 639 0.9× 329 0.9× 85 0.3× 201 0.8× 162 1.0× 48 1.2k
Menghan Liu China 18 528 0.8× 159 0.4× 297 1.0× 124 0.5× 92 0.6× 56 1.2k
Saroj Nepal South Korea 18 593 0.9× 191 0.5× 163 0.5× 284 1.1× 43 0.3× 28 1.2k
Meng Fang China 20 456 0.7× 224 0.6× 119 0.4× 212 0.8× 66 0.4× 102 1.2k
Huaping Li China 25 638 0.9× 359 1.0× 68 0.2× 197 0.8× 72 0.5× 57 1.6k
Jingnan Li China 18 854 1.3× 284 0.8× 231 0.8× 148 0.6× 88 0.6× 95 1.7k
Yanna Shen China 22 910 1.3× 146 0.4× 171 0.6× 190 0.7× 93 0.6× 45 1.5k
Atieh Pourbagheri‐Sigaroodi Iran 22 638 0.9× 214 0.6× 158 0.5× 97 0.4× 224 1.4× 59 1.4k

Countries citing papers authored by Wei-Feng Huang

Since Specialization
Citations

This map shows the geographic impact of Wei-Feng Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Feng Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Feng Huang more than expected).

Fields of papers citing papers by Wei-Feng Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei-Feng Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Feng Huang. The network helps show where Wei-Feng Huang may publish in the future.

Co-authorship network of co-authors of Wei-Feng Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei-Feng Huang. A scholar is included among the top collaborators of Wei-Feng Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei-Feng Huang. Wei-Feng Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Huang, Wei-Feng, Chao Wang, Yifei Wang, et al.. (2025). Harnessing the innate immune system: a novel bispecific antibody targeting CD47 and CD24 for selective tumor clearance. Journal for ImmunoTherapy of Cancer. 13(12). e013283–e013283.
5.
Huang, Wei-Feng, et al.. (2025). Association between cardiovascular health and metabolic dysfunction-associated steatotic liver disease: a nationwide cross-sectional study. Journal of Health Population and Nutrition. 44(1). 9–9.
6.
Wang, Hai‐Xing, Lin Han, Ying Huang, et al.. (2025). Endoscopic characteristics and treatment modalities of gastrointestinal glomus tumors: a multicenter retrospective study. BMC Gastroenterology. 25(1). 499–499.
7.
Wen, Xin, Dan Li, Hankun Wang, et al.. (2024). IQGAP1 domesticates macrophages to favor mycobacteria survival via modulating NF-κB signal and augmenting VEGF secretion. International Immunopharmacology. 138. 112549–112549. 1 indexed citations
8.
Liu, Wei, et al.. (2024). Abdominal imaging and endoscopic characteristics of adult abdominal IgA vasculitis: a multicenter retrospective study. Annals of Medicine. 56(1). 2408467–2408467. 5 indexed citations
9.
Li, Zuohong, Jianping Chen, Zhaohao Huang, et al.. (2024). Topical application of 666-15, a potent inhibitor of CREB, alleviates alkali-induced corneal neovascularization. Experimental Eye Research. 250. 110165–110165. 2 indexed citations
10.
Chen, Guo, Wenping Xu, Yulan Huang, et al.. (2024). Molecular Characteristics of Staphylococcus aureus Isolates form Food-Poisoning Outbreaks (2011–2022) in Sichuan, China. Foodborne Pathogens and Disease. 21(5). 323–330. 3 indexed citations
12.
Huang, Wei-Feng, et al.. (2023). Splenic Pseudotumor-Like Follicular Dendritic Cell Sarcoma. Journal of Gastrointestinal Surgery. 27(7). 1486–1488. 1 indexed citations
13.
Wu, Na, Zhong Xu, & Wei-Feng Huang. (2023). Tuberculous peritonitis. Digestive and Liver Disease. 56(2). 367–368. 1 indexed citations
14.
Wang, Xu, et al.. (2023). Cap Polyposis. Digestive and Liver Disease. 55(9). 1295–1296.
15.
Huang, Wei-Feng, et al.. (2022). Multiple Primary Rectal and Gastric Mucosa Lymphoid Lesions – Marginal Zone Non-Hodgkin B-Cell Lymphoma. Indian Journal of Surgery. 84(5). 1117–1119.
16.
Li, Ji, et al.. (2022). High-Dose Dual Therapy Versus Bismuth-Containing Quadruple Therapy for the Treatment of Helicobacter pylori Infection: A Systematic Review with Meta-Analysis. The Turkish Journal of Gastroenterology. 33(6). 454–462. 6 indexed citations
17.
Wagner, Abram L., et al.. (2022). Willingness to pay for HPV vaccine among female health care workers in a Chinese nationwide survey. BMC Health Services Research. 22(1). 1324–1324. 13 indexed citations
18.
Huang, Wei-Feng, et al.. (2021). Primary Malignant Anorectal Melanoma. Journal of Gastrointestinal Surgery. 26(1). 263–265. 1 indexed citations
19.
Huang, Wei-Feng, Juan Yu, & Wei Liu. (2021). Hereditary Angioedema of the Small Bowel. Journal of Gastrointestinal Surgery. 26(1). 266–267.
20.
Ho, Yen‐Peng, et al.. (2010). β-Actin is a downstream effector of the PI3K/AKT signaling pathway in myeloma cells. Molecular and Cellular Biochemistry. 348(1-2). 129–139. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026